Brokerages Set Intuitive Surgical, Inc. (NASDAQ:ISRG) Price Target at $446.45

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) have been given an average recommendation of “Moderate Buy” by the twenty analysts that are currently covering the company, MarketBeat reports. Five investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $446.45.

ISRG has been the topic of a number of recent analyst reports. Barclays raised their price target on shares of Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a report on Thursday, July 18th. Piper Sandler raised their target price on shares of Intuitive Surgical from $490.00 to $495.00 and gave the stock an “overweight” rating in a report on Friday, July 19th. Redburn Atlantic upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and boosted their target price for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. Evercore ISI dropped their price target on Intuitive Surgical from $425.00 to $410.00 and set an “in-line” rating on the stock in a research note on Friday, July 19th. Finally, JPMorgan Chase & Co. upped their price objective on Intuitive Surgical from $475.00 to $495.00 and gave the company an “overweight” rating in a research report on Friday, July 19th.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction dated Thursday, August 29th. The stock was sold at an average price of $482.21, for a total transaction of $90,655.48. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,655,048.26. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $482.21, for a total transaction of $90,655.48. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,655,048.26. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Myriam Curet sold 2,818 shares of the business’s stock in a transaction on Tuesday, July 23rd. The stock was sold at an average price of $458.13, for a total transaction of $1,291,010.34. Following the completion of the transaction, the executive vice president now directly owns 298 shares in the company, valued at approximately $136,522.74. The disclosure for this sale can be found here. Insiders sold a total of 53,120 shares of company stock valued at $25,528,753 over the last three months. Corporate insiders own 0.90% of the company’s stock.

Institutional Investors Weigh In On Intuitive Surgical

Large investors have recently made changes to their positions in the company. Capital Research Global Investors purchased a new position in Intuitive Surgical during the 1st quarter valued at approximately $374,390,000. Coatue Management LLC increased its position in Intuitive Surgical by 65.7% in the fourth quarter. Coatue Management LLC now owns 1,301,595 shares of the medical equipment provider’s stock worth $439,106,000 after purchasing an additional 516,054 shares during the last quarter. Vanguard Group Inc. raised its stake in Intuitive Surgical by 1.6% during the first quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider’s stock valued at $12,319,358,000 after purchasing an additional 493,126 shares in the last quarter. Edgewood Management LLC raised its stake in Intuitive Surgical by 7.9% during the fourth quarter. Edgewood Management LLC now owns 5,131,066 shares of the medical equipment provider’s stock valued at $1,731,016,000 after purchasing an additional 374,667 shares in the last quarter. Finally, BNP PARIBAS ASSET MANAGEMENT Holding S.A. grew its stake in shares of Intuitive Surgical by 51.2% in the 1st quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 893,341 shares of the medical equipment provider’s stock worth $356,524,000 after buying an additional 302,382 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Trading Down 1.5 %

ISRG stock opened at $479.18 on Tuesday. The stock’s 50 day simple moving average is $473.03 and its 200 day simple moving average is $428.49. Intuitive Surgical has a 12-month low of $254.85 and a 12-month high of $496.18. The stock has a market capitalization of $169.97 billion, a PE ratio of 86.49, a price-to-earnings-growth ratio of 5.39 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The firm had revenue of $2.01 billion for the quarter, compared to the consensus estimate of $1.97 billion. During the same period in the prior year, the company posted $1.18 earnings per share. The company’s quarterly revenue was up 14.5% on a year-over-year basis. On average, research analysts predict that Intuitive Surgical will post 5.22 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.